Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Show more...
FAQ
Agios Pharmaceuticals 今天的股價是多少?▼
AGIO 目前價格為 $28.16 USD,過去 24 小時上漲了 +2.62%。在圖表上更密切關注 Agios Pharmaceuticals 股價表現。
Agios Pharmaceuticals 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Agios Pharmaceuticals 的股票以代號 AGIO 進行交易。
Agios Pharmaceuticals 的股價在上漲嗎?▼
AGIO 股票較上週下跌 -1.78%,本月上漲 +3.61%,過去一年 Agios Pharmaceuticals 下跌 -16.23%。
Agios Pharmaceuticals 的市值是多少?▼
今天 Agios Pharmaceuticals 的市值為 1.64B
Agios Pharmaceuticals 下一次財報日期是什麼時候?▼
Agios Pharmaceuticals 將於 February 12, 2026 公布下一次財報。
Agios Pharmaceuticals 上一季度的財報如何?▼
AGIO 上一季度的財報為每股 -1.78 USD,預估為 -1.9 USD,帶來 +6.14% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Agios Pharmaceuticals 去年的營收是多少?▼
Agios Pharmaceuticals 去年的營收為 73MUSD。
Agios Pharmaceuticals 去年的淨利是多少?▼
AGIO 去年的淨收益為 1.35BUSD。
Agios Pharmaceuticals 有多少名員工?▼
截至 February 03, 2026,公司共有 486 名員工。
Agios Pharmaceuticals 位於哪個產業?▼
Agios Pharmaceuticals從事於Health Care產業。
Agios Pharmaceuticals 何時完成拆股?▼
Agios Pharmaceuticals 最近沒有進行任何拆股。
Agios Pharmaceuticals 的總部在哪裡?▼
Agios Pharmaceuticals 的總部位於 US 的 Cambridge。